In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Natco Pharma Ltd.

Latest From Natco Pharma Ltd.

AZ's Brilinta Patents 'Vulnerable' To Challenge In India

An Indian court has lifted restraining orders against Micro Labs, Dr Reddy’s and Natco and held that they have made a “strong credible challenge” to the validity of AstraZeneca’s patents for Brilinta in the country. The UK firm has appealed the order.

India Intellectual Property

Deciphering E-Pharmacy Discounts For Novartis’s Ceritinib In India

Novartis’s anticancer Spexib was being offered at a hefty 69% discount to patients in India, highlighting what some experts suggest is the striking pricing structure and business practices at e-pharmacies in the country.

India Commercial

Manufacturing Round-Up: Dr Reddy’s Receives Form 483 With Five Observations

As firms including Laurus Labs, Natco and Strides get GMP compliance nods, the FDA has pulled up Dr Reddy’s for GMP compliance issues. Meanwhile, Numaferm has struck a licensing deal and Olon has started constructing a new plant.

Manufacturing Compliance

Novartis Ceritinib India Case: Court Rebuke Amid Wait For Patent Decision

An Indian court has frowned upon Novartis and opponent Natco for seemingly delaying proceedings before the Controller General of Patents in a case concerning the Swiss firm’s anticancer ceritinib. The patent office wasn’t spared either, with the court asking the Controller to ensure that once orders are reserved, a time period is prescribed for delivering the decision.

India Legal Issues
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Natco Pharma Ltd.
  • Senior Management
  • P. Bhaskara Narayana, CFO
    VC Nannapaneni, Chmn. & Managing Dir.
    Aks Bhujanga Rao, Pres., R&D
  • Contact Info
  • Natco Pharma Ltd.
    Phone: (91) 40 2354 7532
    Natco House, Road No. 2
    Banjara Hills
    Hyderabad, 500033